Mat Calder

Company: PhoreMost

Job title: Principal Medicinal Chemist

Seminars:

Bifunctional Degrader Discovery with PROTEINi Screening 10:00 am

-Small molecule degrader development is hampered by a low complexity matrix of E3 recruitment modules featuring a high degree of POI-specificity High throughput phenotypic screening using programmable PROTEINi has enabled new drug discovery which exploits novel and unprecedented E3 ligases  PROTEINi provides a phenotypically validated molecular start point which can be used as the foundation…Read more

day: Day Two